Topic · page 28 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,081–1,120 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

RMD Open23 Nov 2023
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
Cohort study
RMD Open23 Nov 2023
Time-varying risks of infection in patients as they proceed through the phases of ‘pre-RA’: results from the Scottish Early RA inception cohort
Cohort study
Clin Exp Rheumatol23 Nov 2023
Association between Life's Essential 8 and all-cause or cardiovascular-specific mortality in patients with rheumatoid arthritis
Cohort study
Rheumatology (Oxford)22 Nov 2023
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis
Cohort study
Semin Arthritis Rheum22 Nov 2023
Beyond the surface - Autoreactive B cells in human autoimmune diseases
Mechanistic study
Arthritis Res Ther22 Nov 2023
Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach
Cohort study
Rheumatology (Oxford)21 Nov 2023
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis
Cohort study
Arthritis Res Ther20 Nov 2023
Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review
Meta-analysis
RMD Open16 Nov 2023
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis
Cohort study
Arthritis Rheumatol15 Nov 2023
Computer Vision Analysis of Rheumatoid Arthritis Synovium Reveals Lymphocytic Inflammation Is Associated With Immunoglobulin Skewing in Blood
Mechanistic study
RMD Open14 Nov 2023
Causal effects of time-varying body size on selected autoimmune disorders: a life course Mendelian randomisation study
Research article
Arthritis Res Ther13 Nov 2023
Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study
Research article
Arthritis Care Res (Hoboken)13 Nov 2023
Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference
Cross-sectional study
Clin Exp Rheumatol12 Nov 2023
Ultrasound versus clinical remission in patients with early rheumatoid arthritis: concordance and relationship with therapy discontinuation
Cross-sectional study
Rheumatology (Oxford)11 Nov 2023
Patient-reported swelling in arthralgia patients at risk for rheumatoid arthritis: is it of value?
Cohort study
Semin Arthritis Rheum10 Nov 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Cohort study
Semin Arthritis Rheum10 Nov 2023
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis
Cohort study
RMD Open9 Nov 2023
Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
Cohort study
Arthritis Rheumatol9 Nov 2023
A Randomized, Double‐Blind, Sham‐Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
Randomized controlled trial
Rheumatology (Oxford)6 Nov 2023
Longitudinal reciprocal association between rheumatoid arthritis and chronic obstructive pulmonary disease and mediation of inflammation
Cohort study
Clin Exp Rheumatol6 Nov 2023
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset
Cohort study
Arthritis Rheumatol5 Nov 2023
Synovial Tissue Heterogeneity in Japanese Patients With Rheumatoid Arthritis Elucidated Using a Cell‐Type Deconvolution Approach
Mechanistic study
Semin Arthritis Rheum3 Nov 2023
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan
Cohort study
Arthritis Res Ther2 Nov 2023
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
Meta-analysis
Rheumatology (Oxford)2 Nov 2023
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study
Cohort study
Rheumatology (Oxford)2 Nov 2023
Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction
Cohort study
RMD Open1 Nov 2023
Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts
Cohort study
J Rheumatol1 Nov 2023
Use of Coordinator Role Improves Access to Rheumatologic Advanced Therapy
Cohort study
Rheumatology (Oxford)1 Nov 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy
Research article
Rheumatology (Oxford)1 Nov 2023
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
Cohort study
Lancet RheumatolNovember 2023
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials
Randomized controlled trial
Scand J Rheumatol31 Oct 2023
Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
Cross-sectional study
Clin Exp Rheumatol31 Oct 2023
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population
Cohort study
RMD Open31 Oct 2023
Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System
Cohort study
Arthritis Res Ther30 Oct 2023
Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis
Diagnostic or prognostic study
Arthritis Care Res (Hoboken)30 Oct 2023
Multimorbidity Patterns and Rheumatoid Arthritis Disease Outcomes: Findings From a Multicenter, Prospective Cohort
Cohort study
RMD Open29 Oct 2023
Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
Meta-analysis
RMD Open25 Oct 2023
Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
Cohort study
RMD Open25 Oct 2023
Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting
Cohort study
Rheumatology (Oxford)23 Oct 2023
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis
Cohort study

All 1,564 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,564, newest first